Date published: 2025-12-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

FBXW28 Activators

FBXW28, a crucial component of the ubiquitin-proteasome system, is regulated and activated by a range of chemical compounds, each influencing specific signaling pathways that culminate in enhanced activity of FBXW28. Forskolin, for example, increases intracellular cAMP levels, activating PKA, which can phosphorylate substrates in the ubiquitination process, thus indirectly enhancing the activity of FBXW28. Similarly, MG132 and Bortezomib, both proteasome inhibitors, lead to an accumulation of ubiquitinated proteins. This accumulation indirectly necessitates increased activity of FBXW28 to manage the heightened demand for protein degradation. Epigallocatechin gallate, acting as a kinase inhibitor, indirectly enhances FBXW28 activity by reducing competitive kinase activity, thus influencing the ubiquitination process more favorably for FBXW28. LY294002 and Wortmannin, both PI3K inhibitors, reduce AKT phosphorylation and activity, leading to an environment where FBXW28's role in ubiquitination becomes more prominent due to decreased AKT-mediated survival signaling.

Furthermore, the functional dynamics of FBXW28 are intricately influenced by compounds like Rapamycin, SB203580, U0126, and Thapsigargin, each playing a unique role in enhancing FBXW28 activity. Rapamycin, through mTOR inhibition, shifts the cellular balance towards protein degradation, thus indirectly enhancing the ubiquitination role of FBXW28. SB203580, a p38 MAPK inhibitor, and U0126, a MEK1/2 inhibitor, alter signaling pathways in a way that favors FBXW28's involvement in protein turnover and degradation. Thapsigargin, by increasing cytosolic calcium levels, activates calcium-dependent enzymes and pathways, indirectly enhancing the ubiquitination process where FBXW28 is a key player. Lastly, Staurosporine, a broad-spectrum kinase inhibitor, enhances FBXW28 activity by reducing kinase-mediated competition in the ubiquitin-proteasome pathway, thus allowing FBXW28 to more effectively target proteins for degradation. Collectively, these compounds, through their targeted effects on cellular signaling, facilitate the enhancement of FBXW28-mediated functions, emphasizing its role in the critical process of protein ubiquitination and degradation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Increases intracellular cAMP, activating PKA, which enhances FBXW28's activity in protein ubiquitination by phosphorylating substrates within the ubiquitin-proteasome system.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

A proteasome inhibitor that causes ubiquitinated proteins' accumulation, indirectly enhancing FBXW28's role in ubiquitin-mediated protein degradation.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

Acts as a kinase inhibitor, reducing competitive kinase activity, thus indirectly enhancing FBXW28's activity in the ubiquitin-proteasome pathway.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that reduces AKT activity, leading to enhanced FBXW28 activity in protein ubiquitination due to decreased AKT-mediated survival signaling.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR, altering the balance of protein synthesis and degradation, indirectly enhancing FBXW28's ubiquitination role due to increased need for proteasomal degradation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor that indirectly enhances FBXW28 activity by altering signaling pathways that regulate protein turnover, where FBXW28 is involved.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Inhibits MEK1/2 in the MAPK pathway, shifting focus towards degradation pathways and enhancing FBXW28's activity in the ubiquitin-proteasome system.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Similar to LY294002, this PI3K inhibitor reduces AKT phosphorylation and activity, enhancing FBXW28's ubiquitination activity by making more substrates available for ubiquitination.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

A SERCA inhibitor that increases cytosolic calcium levels, indirectly enhancing FBXW28 activity in protein ubiquitination through calcium-dependent signaling pathways.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Another proteasome inhibitor leading to ubiquitinated proteins' accumulation, enhancing FBXW28's functional activity in targeting proteins for ubiquitination.